600557 康緣藥業
按盤價 
13.560 +0.020 (+0.148%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.326 | 8.289 | 9.576 | 9.592 | 7.568 |
| 總資產報酬率 ROA (%) | 2.926 | 5.560 | 6.638 | 6.781 | 5.282 |
| 投入資產回報率 ROIC (%) | 4.265 | 8.195 | 9.314 | 9.063 | 6.873 | 邊際利潤分析 |
| 銷售毛利率 (%) | 69.465 | 73.217 | 74.277 | 72.096 | 71.906 |
| 營業利潤率 (%) | 11.097 | 9.865 | 9.474 | 10.453 | 9.620 |
| 息稅前利潤/營業總收入 (%) | 10.630 | 10.015 | 9.199 | 10.041 | 9.222 |
| 淨利潤/營業總收入 (%) | 8.866 | 9.773 | 9.130 | 10.157 | 8.890 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 79.496 | 76.971 | 90.392 | 91.827 | 94.374 |
| 價值變動淨收益/利潤總額(%) | 1.938 | 5.333 | 3.302 | 0.942 | 1.236 |
| 營業外收支淨額/利潤總額(%) | -2.695 | 0.064 | -2.859 | -2.040 | -6.920 | 償債能力分析 |
| 流動比率 (X) | 1.998 | 1.759 | 1.996 | 2.094 | 1.978 |
| 速動比率 (X) | 1.729 | 1.495 | 1.824 | 1.902 | 1.746 |
| 資產負債率 (%) | 27.113 | 31.877 | 30.191 | 27.396 | 25.678 |
| 帶息債務/全部投入資本 (%) | -2.227 | -2.011 | -1.694 | 2.969 | 4.527 |
| 股東權益/帶息債務 (%) | -4,425.793 | -4,901.201 | -5,850.624 | 3,213.404 | 2,064.423 |
| 股東權益/負債合計 (%) | 257.965 | 205.052 | 227.604 | 255.353 | 278.546 |
| 利息保障倍數 (X) | -60.705 | 69.751 | -760.238 | -49.439 | 41.010 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 58.419 | 54.316 | 51.014 | 60.413 | 83.245 |
| 存貨周轉天數 (天) | 185.988 | 153.529 | 99.693 | 100.950 | 125.488 |
| 備註： | 即時報價更新時間為 25/03/2026 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
